Department of Defense funds two MDMA therapy studies for soldiers with PTSD
Updated
Updated · The Guardian · Apr 30
Department of Defense funds two MDMA therapy studies for soldiers with PTSD
5 articles · Updated · The Guardian · Apr 30
The $4.9m grants go to Walter Reed and Emory-led researchers, with 186 active-duty, guard and reserve personnel expected to enrol and therapist training starting next week.
Recruitment could begin later this year, with dosing likely in 2027, in the first official studies of psychedelics' effects on serving US soldiers.
Backers say the work could help curb PTSD and veteran suicide and eventually become standard military care, while critics warn it could be used to restore troops for redeployment.
After the FDA's 2024 rejection, can these new military studies finally prove MDMA therapy is safe and effective for PTSD treatment?
Could MDMA therapy become a tool to quickly return soldiers to combat, or will it prioritize their long-term mental well-being?